https://m2.mtmt.hu/ hun 2026-09-22 19:47 JournalArticle 32583471 VALIDATED true 0 false 2026-08-25T08:51:14.580+0000 2023-12-15T10:21:30.490+0000 2022-01-10T10:08:12.969+0000 true 10065463 Turek Márta /api/admin/10065463 Admin Turek Márta (KOKI admin 4) true 2026-08-12T12:45:14.161+0000 2026-08-12T12:45:14.161+0000 2023-12-15T10:21:30.900+0000 true 10003134 Wolf György /api/admin/10003134 Admin Wolf György (MTMT Központi admin) true 10003134 Admin 10067876 /api/admin/10067876 Ladányi Gusztáv (MTMT API user, admin) Ladányi Gusztáv true true Admin 10080106 /api/admin/10080106 Király Magdolna (MTMT ellenőrzés admin5) Király Magdolna true true 2024-10-17T16:46:05.635+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Iring, András true true /api/journal/3622 REVIEWED PHARMACOLOGICAL RESEARCH 1043-6618 1096-1186 true false 3622 false 3622 true 1043-6618 1096-1186 Journal FOREIGN 176 106045 106045 16 2022 Funding 2006792 /api/funding/2006792 Hungarian Research and Develop-ment Fund(116654) false true Funding 2006793 /api/funding/2006793 Hungarian Research and Develop-ment Fund(131629) false true Funding 2006794 /api/funding/2006794 Hungarian Brain Research Program(2017-1.2.1-NKP-2017-00002) false true Funding 2006795 /api/funding/2006795 Hungarian Academy of Sciences Premium Postdoctoral Research Program(PPD2019-20/2019-439.) false true true true 2022 true true true false true false GOLD 2026-08-25 true https://real.mtak.hu/135720 21 0 21 19 2 21 21 18 21 21 21 19 19 19 2 0 21 19 21 19 0 13 13 Folyóiratcikk Journal Article 24 18 Könyvrészlet Chapter in Book 25 3 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2022 0 3 3 3 3 2023 0 8 7 8 7 2024 0 4 3 4 3 2025 0 4 4 4 4 2026 0 2 2 2 2 D1 false 10008942,10052098 false false false 2022-01-11T12:23:54.307+0000 Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (KOKI / GYO); Neuroimmunológiai Kutatócsoport (HRN KOKI); Neurológiai Klinika (SE / AOK / K); Neurológiai Tanszék (DE / ÁOK); Pathologiai Intézet (SZTE / SZAOK) 11 37 6 11 0 true 10080106 10067876 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 99941314 /api/authorship/99941314 Iring, András [Iring, András (Élettan), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO) 1 0.091 true false false Author 10032256 /api/author/10032256 Iring András (Élettan) Iring András true 10032256 true Iring András true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941315 /api/authorship/99941315 Tóth, Adrián [Tóth, Adrián (Neurológia), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO); Neurológiai Klinika (SE / AOK / K) 2 0.091 false false false Author 10053045 /api/author/10053045 Tóth Adrián (Neurológia) Tóth Adrián true 10053045 true Tóth Adrián true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941316 /api/authorship/99941316 Baranyi, Mária [Baranyi, Mária (Molekuláris farma...), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO) 3 0.091 false false false Author 91 /api/author/91 Baranyi Mária (Molekuláris farmakológia) Baranyi Mária true 91 true Baranyi Mária true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941317 /api/authorship/99941317 Otrokocsi, Lilla [Bereczkiné Otrokocsi, Lilla (élettudomány), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO) 4 0.091 false false false Author 10055678 /api/author/10055678 Bereczkiné Otrokocsi Lilla (élettudomány) Bereczkiné Otrokocsi Lilla true 10055678 true Otrokocsi Lilla true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941318 /api/authorship/99941318 Módis, László V. [Módis, László (egészségtudományok), szerző] Neurológiai Tanszék (DE / ÁOK) 5 0.09090909 false false false Author 10078363 /api/author/10078363 Módis László (egészségtudományok) Módis László true true Módis László V. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941319 /api/authorship/99941319 Gölöncsér, Flóra [Gölöncsér, Flóra (idegtudományok), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO) 6 0.091 false false false Author 10052098 /api/author/10052098 Gölöncsér Flóra (idegtudományok) Gölöncsér Flóra true 10052098 true Gölöncsér Flóra true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941320 /api/authorship/99941320 Varga, Bernadett [Iring-Varga, Bernadett (funkcionális ideg...), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO); Doktori Iskola (SE) 7 0.091 false false false Author 10076833 /api/author/10076833 Iring-Varga Bernadett (funkcionális idegtudomány) Iring-Varga Bernadett true true Varga Bernadett true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941321 /api/authorship/99941321 Hortobágyi, Tibor [Hortobágyi, Tibor (Neuropathológia), szerző] Pathologiai Intézet (SZTE / SZAOK); Neurológiai Tanszék (DE / ÁOK) 8 0.09090909 false false false Author 10017334 /api/author/10017334 Hortobágyi Tibor (Neuropathológia) Hortobágyi Tibor true 10017334 true Hortobágyi Tibor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941322 /api/authorship/99941322 Bereczki, Dániel [Bereczki, Dániel (Stroke), szerző] Neurológiai Klinika (SE / AOK / K) 9 0.091 false false false Author 10000800 /api/author/10000800 Bereczki Dániel (Stroke) Bereczki Dániel true 10000800 true Bereczki Dániel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941323 /api/authorship/99941323 Dénes, Ádám [Dénes, Ádám (Neurobiológia, ne...), szerző] Neuroimmunológiai Kutatócsoport (HRN KOKI) 10 0.091 false false false Author 10012934 /api/author/10012934 Dénes Ádám (Neurobiológia, neuroimmunológia) Dénes Ádám true 10012934 true Dénes Ádám true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 99941324 /api/authorship/99941324 Sperlágh, Beáta ✉ [Sperlágh, Beáta (Neurofarmakológia), szerző] Molekuláris Farmakológia Kutatócsoport (KOKI / GYO); Doktori Iskola (SE) 11 0.091 false true true Author 10008942 /api/author/10008942 Sperlágh Beáta (Neurofarmakológia) Sperlágh Beáta true 10008942 true Sperlágh Beáta true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 20384796 /api/publicationidentifier/20384796 DOI: 10.1016/j.phrs.2021.106045 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.phrs.2021.106045 https://doi.org/10.1016/j.phrs.2021.106045 false true PublicationIdentifier 20392395 /api/publicationidentifier/20392395 REAL: 135720 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GOLD true 135720 https://real.mtak.hu/135720 false true PublicationIdentifier 20964651 /api/publicationidentifier/20964651 WoS: 000788113000002 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000788113000002 https://www.webofscience.com/wos/woscc/full-record/000788113000002 false true PublicationIdentifier 20389912 /api/publicationidentifier/20389912 Scopus: 85122177537 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85122177537 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85122177537 false true PublicationIdentifier 20384826 /api/publicationidentifier/20384826 PubMed: 34968684 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34968684 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34968684&dopt=Abstract false true Classification 12197 /api/classification/12197 Gyógyszerészet, farmakogenomika, gyógyszerkutatás és tervezés, gyógyszeres kezelés true true Keyword 1002285 /api/keyword/1002285 microglia true 1002285 true Keyword 1335302 /api/keyword/1335302 G-protein coupled receptor true 1335302 true Keyword 1717534 /api/keyword/1717534 Parkinson's disease. true true Keyword 2560416 /api/keyword/2560416 P2Y(12)-receptor true true SjrRating 11321389 /api/sjrrating/11321389 sjr:D1 (2022) Scopus - Pharmacology PHARMACOLOGICAL RESEARCH 1043-6618 1096-1186 16 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 3004 /api/classificationexternal/3004 Scopus - Pharmacology true 3004 true D1 DIRECT true true Reference 26438818 /api/reference/26438818 1. Parkinson 2002: An essay on the shaking palsy. 1817., J. Neuropsychiatry Clin. Neurosci., 14, p. 223, DOI: 10.1176/jnp.14.2.223 1 10.1176/jnp.14.2.223 false true Reference 26438819 /api/reference/26438819 2. Simon 2020: Parkinson disease epidemiology, pathology, genetics, and pathophysiology., Clin. Geriatr. Med., 36, p. 1, DOI: 10.1016/j.cger.2019.08.002 2 10.1016/j.cger.2019.08.002 false true Reference 26438820 /api/reference/26438820 3. Pinter 2015: Mortality in Parkinson’s disease: a 38-year follow-up study., Mov. Disord., 30, p. 266, DOI: 10.1002/mds.26060 3 10.1002/mds.26060 false true Reference 26438821 /api/reference/26438821 4. Dorsey 2018: The emerging evidence of the Parkinson pandemic., J. Parkinson’s Dis., 8, p. S3, DOI: 10.3233/JPD-181474 4 10.3233/JPD-181474 false true Reference 26438822 /api/reference/26438822 5. Jellinger 2007: Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study., J. Neural Transm., 72, p. 91 5 false true Reference 26438823 /api/reference/26438823 6. Jacobson 2020: Update of P2Y receptor pharmacology: IUPHAR review 27., Br. J. Pharmacol., 177, p. 2413, DOI: 10.1111/bph.15005 6 10.1111/bph.15005 false true Reference 26438824 /api/reference/26438824 7. Moore 2015: P2Y12 expression and function in alternatively activated human microglia., Neurol. Neuroimmunol. Neuroinflamm., 2, DOI: 10.1212/NXI.0000000000000080 7 10.1212/NXI.0000000000000080 false true Reference 26438825 /api/reference/26438825 8. Moskal 2020: McQuibban. ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway., Nat. Commun., 11, p. 019, DOI: 10.1038/s41467-019-13781-3 8 10.1038/s41467-019-13781-3 false true Reference 26438826 /api/reference/26438826 9. Beko 2017: Contribution of platelet P2Y12 receptors to chronic Complete Freund’s adjuvant-induced inflammatory pain., J. Thromb. Haemost., 15, p. 1223, DOI: 10.1111/jth.13684 9 10.1111/jth.13684 false true Reference 26438827 /api/reference/26438827 10. Cserep 2020: Microglia monitor and protect neuronal function via specialized somatic purinergic junctions., Microcontact, 367, p. 528 10 false true Reference 26438828 /api/reference/26438828 11. Haynes 2006: The P2Y12 receptor regulates microglial activation by extracellular nucleotides., Nat. Neurosci., 9, p. 1512, DOI: 10.1038/nn1805 11 10.1038/nn1805 false true Reference 26438829 /api/reference/26438829 12. Gelders 2018: Linking neuroinflammation and neurodegeneration in Parkinson’s disease., J. Immunol. Res., 16 12 false true Reference 26438830 /api/reference/26438830 13. McGeer 1988: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains., Neurology, 38, p. 1285, DOI: 10.1212/WNL.38.8.1285 13 10.1212/WNL.38.8.1285 false true Reference 26438831 /api/reference/26438831 14. Lambert 2010: Distinct migratory and cytokine responses of human microglia and macrophages to ATP., Brain Behav. Immun., 24, p. 1241, DOI: 10.1016/j.bbi.2010.02.010 14 10.1016/j.bbi.2010.02.010 false true Reference 26438832 /api/reference/26438832 15. Williams 1992: Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes., J. Neuropathol. Exp. Neurol., 51, DOI: 10.1097/00005072-199209000-00009 15 10.1097/00005072-199209000-00009 false true Reference 26438833 /api/reference/26438833 16. Lewitt 2008: Levodopa for the treatment of Parkinson’s disease., New Engl. J. Med., 359, p. 2468, DOI: 10.1056/NEJMct0800326 16 10.1056/NEJMct0800326 false true Reference 26438834 /api/reference/26438834 17. Kilkenny 2011: Animal research: reporting in vivo experiments--the ARRIVE guidelines., J. Cereb. Blood Flow Metab., 31, p. 991, DOI: 10.1038/jcbfm.2010.220 17 10.1038/jcbfm.2010.220 false true Reference 26438835 /api/reference/26438835 18. McGrath 2015: Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP., Br. J. Pharmacol. 2015 Jul., 172, p. 3189 18 false true Reference 26438836 /api/reference/26438836 19. Horvath 2014: Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents., Neurobiol. Dis., 70, DOI: 10.1016/j.nbd.2014.06.011 19 10.1016/j.nbd.2014.06.011 false true Reference 26438837 /api/reference/26438837 20. Baranyi 2016: B. Sperlagh. Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease., Mol. Neurodegener., 11, p. 015 20 false true Reference 26438838 /api/reference/26438838 21. Mestre 1994: A method to perform direct transcutaneous intrathecal injection in rats., J. Pharm. Toxicol. Methods, 32, p. 197, DOI: 10.1016/1056-8719(94)90087-6 21 10.1016/1056-8719(94)90087-6 false true Reference 26438839 /api/reference/26438839 22. Baqi 2009: High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors., J. Med. Chem., 52, p. 3784, DOI: 10.1021/jm9003297 22 10.1021/jm9003297 false true Reference 26438840 /api/reference/26438840 23. Shiotsuki 2010: A rotarod test for evaluation of motor skill learning., J. Neurosci. Methods, 189, p. 180, DOI: 10.1016/j.jneumeth.2010.03.026 23 10.1016/j.jneumeth.2010.03.026 false true Reference 26438841 /api/reference/26438841 24. Ip 2017: Stereological estimation of dopaminergic neuron number in the mouse substantia nigra using the optical fractionator and standard microscopy equipment., J. Vis. Exp., 1, p. 56103 24 false true Reference 26438842 /api/reference/26438842 25. West 1991: Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator., Anat. Rec., 231, p. 482, DOI: 10.1002/ar.1092310411 25 10.1002/ar.1092310411 false true Reference 26438843 /api/reference/26438843 26. Keuker 2001: How to use the optical fractionator: an example based on the estimation of neurons in the hippocampal CA1 and CA3 regions of tree shrews., Brain Res. Protoc., 7, DOI: 10.1016/S1385-299X(01)00064-2 26 10.1016/S1385-299X(01)00064-2 false true Reference 26438844 /api/reference/26438844 27. Lopez-Lopez 2020: A. Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson’s disease., Br. J. Pharmacol., 28, p. 15275 27 false true Reference 26438845 /api/reference/26438845 28. Paul 2008: The nissl stain: a stain for cell bodies in brain sections., CSH Protoc., 1 28 false true Reference 26438846 /api/reference/26438846 29. Shihan 2021: A simple method for quantitating confocal fluorescent images., Biochem. Biophys. Rep., 25 29 false true Reference 26438847 /api/reference/26438847 30. Lowry 1951: Protein measurement with the Folin phenol reagent., J. Biol. Chem., 193, DOI: 10.1016/S0021-9258(19)52451-6 30 10.1016/S0021-9258(19)52451-6 false true Reference 26438848 /api/reference/26438848 31. Baranyi 2006: Chromatographic analysis of dopamine metabolism in a Parkinsonian model., J. Chromatogr. A, 7, p. 1 31 false true Reference 26438849 /api/reference/26438849 32. Chapman 2009: B.W. McColl. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke., J. Cereb. Blood Flow Metab., 29, p. 1764, DOI: 10.1038/jcbfm.2009.113 32 10.1038/jcbfm.2009.113 false true Reference 26438850 /api/reference/26438850 33. Denes 2010: Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice., J. Neurosci., 30, DOI: 10.1523/JNEUROSCI.1227-10.2010 33 10.1523/JNEUROSCI.1227-10.2010 false true Reference 26438851 /api/reference/26438851 34. Kovanyi 2016: The role of P2×7 receptors in a rodent PCP-induced schizophrenia model., Sci. Rep., 6, p. 36680, DOI: 10.1038/srep36680 34 10.1038/srep36680 false true Reference 26438852 /api/reference/26438852 35. Skogseth 2017: Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology., J. Alzheimers Dis., 59, p. 1139, DOI: 10.3233/JAD-170274 35 10.3233/JAD-170274 false true Reference 26438853 /api/reference/26438853 36. Charan 2013: to calculate sample size for different study designs in medical research?., Indian J. Psychol. Med., 35, p. 121, DOI: 10.4103/0253-7176.116232 36 10.4103/0253-7176.116232 false true Reference 26438854 /api/reference/26438854 37. Hoffmann 2009: Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor., J. Pharmacol. Exp. Ther., 331, p. 648, DOI: 10.1124/jpet.109.156687 37 10.1124/jpet.109.156687 false true Reference 26438855 /api/reference/26438855 38. Charolidi 2015: Microglial Kv1.3 channels and P2Y12 receptors differentially regulate cytokine and chemokine release from brain slices of young adult and aged mice., PLoS One, 10, DOI: 10.1371/journal.pone.0128463 38 10.1371/journal.pone.0128463 false true Reference 26438856 /api/reference/26438856 39. Walker 2020: Patterns of expression of purinergic receptor P2RY12, a putative marker for non-activated microglia, in aged and Alzheimer’s disease brains., Int. J. Mol. Sci., 21, DOI: 10.3390/ijms21020678 39 10.3390/ijms21020678 false true Reference 26438857 /api/reference/26438857 40. Gottlieb 2000: Programmed cell death., Drug N. Perspect., 13, p. 471 40 false true Reference 26438858 /api/reference/26438858 41. Ghavami 2009: Apoptosis and cancer: mutations within caspase genes., J. Med. Genet., 46, p. 497, DOI: 10.1136/jmg.2009.066944 41 10.1136/jmg.2009.066944 false true Reference 26438859 /api/reference/26438859 42. Gresa-Arribas 2012: Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents., PLoS One, 7, p. 20, DOI: 10.1371/journal.pone.0045227 42 10.1371/journal.pone.0045227 false true Reference 26438860 /api/reference/26438860 43. Gaestel 2006: MAPKAP kinases - MKs - two’s company, three’s a crowd., Nat. Rev. Mol. Cell Biol., 7, p. 120, DOI: 10.1038/nrm1834 43 10.1038/nrm1834 false true Reference 26438861 /api/reference/26438861 44. Bachstetter 2010: The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS., Aging Dis., 1, p. 199 44 false true Reference 26438862 /api/reference/26438862 45. Kim 2008: The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression., Nat. Immunol., 9, p. 1019, DOI: 10.1038/ni.1640 45 10.1038/ni.1640 false true Reference 26438863 /api/reference/26438863 46. de Souza 2014: MAPK involvement in cytokine production in response to Corynebacterium pseudotuberculosis infection., BMC Microbiol., 14, p. 014 46 false true Reference 26438864 /api/reference/26438864 47. Cuenda 2007: p38 MAP-kinases pathway regulation, function and role in human diseases., Biochim. Biophys. Acta, 8, p. 24 47 false true Reference 26438865 /api/reference/26438865 48. Tatsumi 2015: RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain., Glia, 63, DOI: 10.1002/glia.22745 48 10.1002/glia.22745 false true Reference 26438866 /api/reference/26438866 49. Albarrán-Juárez 2018: Piezo1 and G(q)/G(11) promote endothelial inflammation depending on flow pattern and integrin activation., J. Exp. Med., 215, p. 2655, DOI: 10.1084/jem.20180483 49 10.1084/jem.20180483 false true Reference 26438867 /api/reference/26438867 50. Walker 2015: Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains., Alzheimers Res. Ther., 7, p. 015, DOI: 10.1186/s13195-015-0139-9 50 10.1186/s13195-015-0139-9 false true Reference 26438868 /api/reference/26438868 51. Dorsam 2004: Central role of the P2Y12 receptor in platelet activation., J. Clin. Investig., 113, p. 340, DOI: 10.1172/JCI20986 51 10.1172/JCI20986 false true Reference 26438869 /api/reference/26438869 52. Butovsky 2014: Identification of a unique TGF-β-dependent molecular and functional signature in microglia., Nat. Neurosci., 17, p. 131, DOI: 10.1038/nn.3599 52 10.1038/nn.3599 false true Reference 26438870 /api/reference/26438870 53. Franke 2004: P2Y receptor expression on astrocytes in the nucleus accumbens of rats., Neuroscience, 127, p. 431, DOI: 10.1016/j.neuroscience.2004.05.003 53 10.1016/j.neuroscience.2004.05.003 false true Reference 26438871 /api/reference/26438871 54. Hodge 2019: Conserved cell types with divergent features in human versus mouse cortex., Nature, 573, p. 61, DOI: 10.1038/s41586-019-1506-7 54 10.1038/s41586-019-1506-7 false true Reference 26438872 /api/reference/26438872 55. Amadio 2006: Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain., Neuroscience, 141, p. 1171, DOI: 10.1016/j.neuroscience.2006.05.058 55 10.1016/j.neuroscience.2006.05.058 false true Reference 26438873 /api/reference/26438873 56. Nimmerjahn 2005: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo., Science, 308, p. 1314, DOI: 10.1126/science.1110647 56 10.1126/science.1110647 false true Reference 26438874 /api/reference/26438874 57. Boche 2013: Review: activation patterns of microglia and their identification in the human brain., Neuropathol. Appl. Neurobiol., 39, p. 3, DOI: 10.1111/nan.12011 57 10.1111/nan.12011 false true Reference 26438875 /api/reference/26438875 58. Benarroch 2013: Microglia: multiple roles in surveillance, circuit shaping, and response to injury., Neurology, 81, p. 1079, DOI: 10.1212/WNL.0b013e3182a4a577 58 10.1212/WNL.0b013e3182a4a577 false true Reference 26438876 /api/reference/26438876 59. Subramaniam 2017: Targeting microglial activation states as a therapeutic avenue in Parkinson’s disease., Front. Aging Neurosci., 9 59 false true Reference 26438877 /api/reference/26438877 60. Imamura 2003: Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains., Acta Neuropathol., 106, p. 518, DOI: 10.1007/s00401-003-0766-2 60 10.1007/s00401-003-0766-2 false true Reference 26438878 /api/reference/26438878 61. Illes 2020: Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS., Cells, 9, DOI: 10.3390/cells9051108 61 10.3390/cells9051108 false true Reference 26438879 /api/reference/26438879 62. Yang 2018: Depletion of microglia augments the dopaminergic neurotoxicity of MPTP., FASEB J., 32, p. 3336, DOI: 10.1096/fj.201700833RR 62 10.1096/fj.201700833RR false true Reference 26438880 /api/reference/26438880 63. Tönges 2012: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease., Brain, 135, p. 3355, DOI: 10.1093/brain/aws254 63 10.1093/brain/aws254 false true Reference 26438881 /api/reference/26438881 64. Fekete 2018: Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms., Acta Neuropathol., 136, p. 461, DOI: 10.1007/s00401-018-1885-0 64 10.1007/s00401-018-1885-0 false true Reference 26438882 /api/reference/26438882 65. Swiatkowski 2016: Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury., Neuroscience, 318, p. 22, DOI: 10.1016/j.neuroscience.2016.01.008 65 10.1016/j.neuroscience.2016.01.008 false true Reference 26438883 /api/reference/26438883 66. Davalos 2005: ATP mediates rapid microglial response to local brain injury in vivo., Nat. Neurosci., 8, p. 752, DOI: 10.1038/nn1472 66 10.1038/nn1472 false true Reference 26438884 /api/reference/26438884 67. Ohsawa 2007: Involvement of P2×4 and P2Y12 receptors in ATP-induced microglial chemotaxis., Glia, 55, p. 604, DOI: 10.1002/glia.20489 67 10.1002/glia.20489 false true Reference 26438885 /api/reference/26438885 68. Yu 2019: P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents., Cell Death Dis., 10, p. 019, DOI: 10.1038/s41419-019-1425-4 68 10.1038/s41419-019-1425-4 false true Reference 26438886 /api/reference/26438886 69. Raingeaud 1995: cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine., J. Biol. Chem., 270, p. 7420, DOI: 10.1074/jbc.270.13.7420 69 10.1074/jbc.270.13.7420 false true Reference 26438887 /api/reference/26438887 70. Han 1994: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells., Science, 265, p. 808, DOI: 10.1126/science.7914033 70 10.1126/science.7914033 false true Reference 26438888 /api/reference/26438888 71. Freshney 1994: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27., Cell, 78, p. 1039, DOI: 10.1016/0092-8674(94)90278-X 71 10.1016/0092-8674(94)90278-X false true Reference 26438889 /api/reference/26438889 72. Scheiblich 2017: Regulation of microglial phagocytosis by RhoA/ROCK-inhibiting drugs., Cell Mol. Neurobiol., 37, p. 461, DOI: 10.1007/s10571-016-0379-7 72 10.1007/s10571-016-0379-7 false true Reference 26438890 /api/reference/26438890 73. Koch 2018: ROCK inhibition in models of neurodegeneration and its potential for clinical translation., Pharmacol. Ther., 189, p. 1, DOI: 10.1016/j.pharmthera.2018.03.008 73 10.1016/j.pharmthera.2018.03.008 false true Reference 26438891 /api/reference/26438891 74. Tatenhorst 2014: Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease., J. Neuropathol. Exp. Neurol., 73, p. 770, DOI: 10.1097/NEN.0000000000000095 74 10.1097/NEN.0000000000000095 false true Reference 26438892 /api/reference/26438892 75. Guo 2013: The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress., Biomed. Res. Int., 430791, p. 22 75 false true Reference 26438893 /api/reference/26438893 76. Andersen 2021: Heritability enrichment implicates microglia in Parkinson’s disease pathogenesis., Ann. Neurol., 27, p. 26032 76 false true /api/publication/32583471 Iring András et al. The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets. (2022) PHARMACOLOGICAL RESEARCH 1043-6618 1096-1186 176<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10032256"><a href="/gui2/?type=authors&mode=browse&sel=10032256" target="_blank">Iring András (<span class="authorship-author-name">Iring András</span> <span class="authorAux-mtmt"> Élettan</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10053045"><a href="/gui2/?type=authors&mode=browse&sel=10053045" target="_blank">Tóth Adrián (<span class="authorship-author-name">Tóth Adrián</span> <span class="authorAux-mtmt"> Neurológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Neurológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="91"><a href="/gui2/?type=authors&mode=browse&sel=91" target="_blank">Baranyi Mária (<span class="authorship-author-name">Baranyi Mária</span> <span class="authorAux-mtmt"> Molekuláris farmakológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10055678"><a href="/gui2/?type=authors&mode=browse&sel=10055678" target="_blank">Otrokocsi Lilla (<span class="authorship-author-name">Bereczkiné Otrokocsi Lilla</span> <span class="authorAux-mtmt"> élettudomány</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10078363"><a href="/gui2/?type=authors&mode=browse&sel=10078363" target="_blank">Módis László V. (<span class="authorship-author-name">Módis László</span> <span class="authorAux-mtmt"> egészségtudományok</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Neurológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10052098"><a href="/gui2/?type=authors&mode=browse&sel=10052098" target="_blank">Gölöncsér Flóra (<span class="authorship-author-name">Gölöncsér Flóra</span> <span class="authorAux-mtmt"> idegtudományok</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10076833"><a href="/gui2/?type=authors&mode=browse&sel=10076833" target="_blank">Varga Bernadett (<span class="authorship-author-name">Iring-Varga Bernadett</span> <span class="authorAux-mtmt"> funkcionális idegtudomány</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport; <span title="Semmelweis Egyetem">SE</span>/Doktori Iskola</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10017334"><a href="/gui2/?type=authors&mode=browse&sel=10017334" target="_blank">Hortobágyi Tibor (<span class="authorship-author-name">Hortobágyi Tibor</span> <span class="authorAux-mtmt"> Neuropathológia</span>) </a> </span> <span class="author-affil"><span title="Szegedi Tudományegyetem">SZTE</span>/<span title="Szent-Györgyi Albert Orvostudományi Kar">SZAOK</span>/Pathologiai Intézet; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Neurológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000800"><a href="/gui2/?type=authors&mode=browse&sel=10000800" target="_blank">Bereczki Dániel (<span class="authorship-author-name">Bereczki Dániel</span> <span class="authorAux-mtmt"> Stroke</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Neurológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10012934"><a href="/gui2/?type=authors&mode=browse&sel=10012934" target="_blank">Dénes Ádám (<span class="authorship-author-name">Dénes Ádám</span> <span class="authorAux-mtmt"> Neurobiológia, neuroimmunológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Neuroimmunológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10008942"><a href="/gui2/?type=authors&mode=browse&sel=10008942" target="_blank">Sperlágh Beáta ✉ (<span class="authorship-author-name">Sperlágh Beáta</span> <span class="authorAux-mtmt"> Neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/<span title="Gyógyszerkutatási Osztály">GYO</span>/Molekuláris Farmakológia Kutatócsoport; <span title="Semmelweis Egyetem">SE</span>/Doktori Iskola</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32583471" target="_blank">The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets</a></div> <div> <span class="journal-title">PHARMACOLOGICAL RESEARCH</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1043-6618">1043-6618</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1096-1186">1096-1186</a>)</span>: <span class="journal-volume">176</span> <span class="page"> Paper 106045. 16 p. </span> <span class="year">(2022)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.phrs.2021.106045" target="_blank" href="https://doi.org/10.1016/j.phrs.2021.106045"> DOI </a> </span> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:black" title="135720" target="_blank" href="https://real.mtak.hu/135720"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000788113000002" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000788113000002"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85122177537" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85122177537"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34968684" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34968684&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 21</span> | Független: 19 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 18 | Scopus jelölt:&nbsp;21 | WoS/Scopus jelölt:&nbsp;21 | DOI jelölt:&nbsp;21 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32583471&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 13 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32583471</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Hungarian Research and Develop-ment Fund(116654), Hungarian Research and Develop-ment Fund(131629), Hungarian National Brain Research Program(2017-1.2.1-NKP-2017-00002), Hungarian Academy of Sciences Premium Postdoctoral Research Program(PPD2019-20/2019-439.) </div> <div class="lastModified">Utolsó módosítás: 2023.12.15. 11:21 Wolf György (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2024.10.17. 18:46 Ladányi Gusztáv (MTMT API user, admin) Király Magdolna (MTMT ellenőrzés admin5) </div> </div></div>